High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
复制标题
DOI:
10.1007/s10461-012-0317-8
复制
发表时间:
2013-07
影响因子:
4.4
通讯作者:
Sanders, Eduard Joachim
中科院分区:
文献类型:
--
作者:
Van der Elst, Elisabeth Maria;Mbogua, Judie;Operario, Don;Mutua, Gaudensia;Kuo, Caroline;Mugo, Peter;Kanungi, Jennifer;Singh, Sagri;Haberer, Jessica;Priddy, Frances;Sanders, Eduard Joachim
This paper used qualitative methods to explore experiences of men who have sex with men and female sex workers in Nairobi and Mtwapa, Kenya, who used oral preexposure prophylaxis (PrEP) for HIV prevention as part of a four-month trial of safety, acceptability and adherence. Fifty-one of 72 volunteers who took part in a randomized, placebo-controlled, blinded trial that compared daily and intermittent dosage of PrEP underwent qualitative assessments after completing the trial. Analyses identified three themes: (i) acceptability of PrEP was high, i.e. side effects were experienced early in the study but diminished over time, however characteristics of pills could improve comfort and use; (ii) social impacts such as stigma, rumors, and relationship difficulties due to being perceived as HIV positive were prevalent; (iii) adherence was challenged by complexities of daily life, in particular post-coital dosing adherence suffered from alcohol use around time of sex, mobile populations, and transactional sex work. These themes resonated across dosing regimens and gender, and while most participants favored the intermittent dosing schedule, those in the intermittent group noted particular challenges in adhering to the post-coital dose. Culturally appropriate and consistent counseling addressing these issues may be critical for PrEP effectiveness.
登录
查看更多内容
DOI:
10.1097/qai.0b013e3181e19a54
发表时间:
2010-08
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Golub SA;Kowalczyk W;Weinberger CL;Parsons JT
通讯作者:
Parsons JT
DOI:
10.1097/qai.0b013e3181e8efe4
发表时间:
2010-09
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Underhill K;Operario D;Skeer M;Mimiaga M;Mayer K
通讯作者:
Mayer K
DOI:
10.1097/qai.0b013e31818d5a27
发表时间:
2009-01-01
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Mimiaga MJ;Case P;Johnson CV;Safren SA;Mayer KH
通讯作者:
Mayer KH
影响因子:
15.8
作者:
Denton PW;Estes JD;Sun Z;Othieno FA;Wei BL;Wege AK;Powell DA;Payne D;Haase AT;Garcia JV
通讯作者:
Garcia JV
影响因子:
168.9
作者:
Paxton, Lynn A.;Hope, Tony;Jaffe, Harold W.
通讯作者:
Jaffe, Harold W.